Muutke küpsiste eelistusi

E-raamat: Handbook of Novel Psychoactive Substances: What Clinicians Should Know about NPS

Edited by (University of Hertfordshire, Hatfield, England), Edited by (Cambridge University, Cambridge, England)
  • Formaat: EPUB+DRM
  • Ilmumisaeg: 10-Oct-2018
  • Kirjastus: Routledge
  • Keel: eng
  • ISBN-13: 9781351655521
  • Formaat - EPUB+DRM
  • Hind: 149,50 €*
  • * hind on lõplik, st. muud allahindlused enam ei rakendu
  • Lisa ostukorvi
  • Lisa soovinimekirja
  • See e-raamat on mõeldud ainult isiklikuks kasutamiseks. E-raamatuid ei saa tagastada.
  • Formaat: EPUB+DRM
  • Ilmumisaeg: 10-Oct-2018
  • Kirjastus: Routledge
  • Keel: eng
  • ISBN-13: 9781351655521

DRM piirangud

  • Kopeerimine (copy/paste):

    ei ole lubatud

  • Printimine:

    ei ole lubatud

  • Kasutamine:

    Digitaalõiguste kaitse (DRM)
    Kirjastus on väljastanud selle e-raamatu krüpteeritud kujul, mis tähendab, et selle lugemiseks peate installeerima spetsiaalse tarkvara. Samuti peate looma endale  Adobe ID Rohkem infot siin. E-raamatut saab lugeda 1 kasutaja ning alla laadida kuni 6'de seadmesse (kõik autoriseeritud sama Adobe ID-ga).

    Vajalik tarkvara
    Mobiilsetes seadmetes (telefon või tahvelarvuti) lugemiseks peate installeerima selle tasuta rakenduse: PocketBook Reader (iOS / Android)

    PC või Mac seadmes lugemiseks peate installima Adobe Digital Editionsi (Seeon tasuta rakendus spetsiaalselt e-raamatute lugemiseks. Seda ei tohi segamini ajada Adober Reader'iga, mis tõenäoliselt on juba teie arvutisse installeeritud )

    Seda e-raamatut ei saa lugeda Amazon Kindle's. 

Handbook of Novel Psychoactive Substances provides an overview of the challenges that clinicians face when dealing with NPS and discusses how the profile of patients and their socio-demographic characteristics frame the serious public health concern that NPS pose. Included are clinical cases from a general perspective, as well as the general account of symptoms, psychopathology, toxicity, and overall clinical management that NPS require. An essential reference for clinicians, this book brings together a diverse and esteemed group of authors to provide a clear and thorough introduction to the problem of NPS and the clinical consequences of this emerging phenomenon.

Author Biographies x
Foreword xxi
Clare Gerada
1 Overcoming the NPS Challenge: An Introduction
1(6)
Ornella Corazza
Andres Roman-Urrestarazu
SECTION ONE NPS Users: Prevalence, Patterns, and Prevention
7(84)
2 The Need for Clinical Guidelines on NPS: NEPTUNE
9(12)
Owen Bowden-Jones
Dima Abdulrahim
3 NPS: Epidemiology, User Group Characteristics, Patterns, Motives, and Problems
21(25)
Mate Kapitany-Foveny
Aviv M. Weinstein
Zsolt Demetrovics
4 The NPS Crisis in British Prisons
46(10)
Shanna Marrinan
Giuseppe Bersani
Ornella Corazza
5 Current Trends in Performance- and Image-Enhancing Substance Use Among Gym Goers, Exercisers, and Athletes
56(35)
Neha P. Ainsworth
Jake Shelley
Andrea Petroczi
SECTION TWO Clinical Recommendations and Best Practices Across Front-Line Health Professionals
91(66)
6 NPS in Emergency Rooms: Dealing With Aggressiveness and Psychomotor Agitation
93(21)
Carla Morganti
Attilio Negri
Laura Cazzaniga
Riccardo C. Gatti
Franca Davanzo
7 A Sentinel and Design Model of Evidence Collection on Acute Drug and NPS Toxicity: The Euro-Den Plus Project
114(18)
Luke De La Rue
David M. Wood
Paul I. Dargan
8 Novel and Traditional Club Substances' Association to Psychopathological and Medical Sequelae: The Ibiza Project
132(25)
Giovanni Martinotti
Cristina Merino Del Villar
Raffaele Giorgetti
Fabrizio Schifano
Massimo Di Giannantonio
SECTION THREE Substances, Adverse Effects, and Clinical Management
157(225)
9 Spice Drugs, Synthetic Cannabinoids, and `Spiceophrenia'
159(10)
Duccio Papanti
Laura Orsolini
John M. Corkery
Fabrizio Schifano
10 Synthetic Cannabinoids, Opioids, and Polydrug Use: Clinical Implications
169(16)
Mariya Prilutskaya
Justin C. Yang
Andres Roman-Urrestarazu
11 Synthetic Cathinones and Related Fatalities in the United Kingdom
185(26)
John M. Corkery
Christine Goodair
Hugh Claridge
12 Marvin the Paranoid Android and Alice in Wonderland: Two Case Reports of Synthetic Cathinone Abuse
211(16)
Pierluigi Simonato
Attilio Negri
Marco Solmi
Rita Santacroce
13 Clinical Aspects Related to Methylphenidate-Based NPS
227(18)
Dino Luthi
Matthias E. Liechti
14 The Worldwide Spread of `Herbal Highs': The Case of Kratom
245(21)
Jessica Neicun
Darshan Singh
Eduardo Cinosi
15 Clinical and Medical Management of Conditions Caused by MDMA or `Ecstasy'
266(25)
Andrew C. Parrott
16 Clinical Effects of 2C-B Abuse
291(13)
Esther Papaseit
Clara Perez-Mana
Debora Gonzalez
Francina Fonseca
Marta Torrens
Magi Farre
17 `In and Out of the Hole': An Exploration of Phencyclidine Derivatives
304(20)
Attilio Negri
Sulaf Assi
18 Fentanyl and Related Opioids: New Trends, Dangers, and Management
324(18)
Esther Papaseit
Magi Farre
Clara Perez-Mana
Adriana Farre
Francina Fonseca
Marta Torrens
19 Designer Benzodiazepines: New Challenges and Treatment Options
342(22)
Peter D. Maskell
Nathan E. Wilson
20 Misuse, Recreational Use, and Addiction in Relation to Prescription Medicines
364(18)
Francesco S. Bersani
Claudio Imperatori
Index 382
Ornella Corazza, MA, PhD, is a Reader in Substance Addictions and Behaviours at the University of Hertfordshire (UK), where she leads a multidisciplinary team across a diverse portfolio in public health and drug policy research. Results of her work have been presented in over a hundred peer-reviewed publications, policy reports and invited lectures internationally.

Andres Roman-Urrestarazu, MD, PhD, specializes in the crossover of psychiatry, substance abuse, health economics, and international health policy. He is currently Gillings Fellow in Global Public Health at the University of Cambridge (UK) and assistant professor at Maastricht University (Netherlands). He has held appointments at Trinity Hall, Cambridge and the London School of Economics and Political Science, working extensively on substance misuse and New Psychoactive Substances.